A Randomized, Double-Blind, Placebo-Controlled, 2-Arm Phase III Study To Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Ricklie Julian
Sponsor
IQVIA RDS Inc.
Unit
Cancer Center Division